Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Research & Development
Samsung Biologics Co Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Research & Development
-₩81.6B
|
CAGR 3-Years
-152%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Research & Development
-₩11.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Research & Development
-₩812m
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Research & Development
-₩28.4B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Research & Development
-₩2.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Research & Development
-₩79.5B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-30%
|
See Also
What is Samsung Biologics Co Ltd's Research & Development?
Research & Development
-81.6B
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Research & Development amounts to -81.6B KRW.
What is Samsung Biologics Co Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-152%
Over the last year, the Research & Development growth was -78%. The average annual Research & Development growth rates for Samsung Biologics Co Ltd have been -152% over the past three years .